BizNews BizNews Radio

BCG vaccine trial update, with Professor Andreas Diacon

Loading player...
Stellenbosch University Professor Andreas Diacon is the force behind a 500-person clinical trial aimed at determining whether the BCG vaccines many South Africans got as children to protect against TB are indeed a shield against Covid-19. The trial involves revaccination of BCG that’s been universally applied in South Africa since 1973. Numerous reports have pointed out a correlation between infection rates for countries where BCG is universally administered as being far lower than in those countries like the USA, Italy and Belgium where it was never used. Learn more about your ad choices. Visit megaphone.fm/adchoices
13 Jul 2020 6AM English South Africa Investing · Business News

Other recent episodes

Magnus Heystek: Why SA’s middle class is quietly being crushed

South Africans are being told everything is fine. Magnus Heystek says it’s a dangerous illusion. In a wide-ranging conversation with Alec Hogg, the veteran investment strategist warns that falling GDP per capita, rising taxes, weak property returns and flawed retirement structures are steadily hollowing out the middle class. From Regulation…
9 Jan 6AM 41 min

South Africa’s business titans are gone – and David Shapiro explains why

From Brian Joffe to Raymond Ackerman, South Africa once produced business giants who shaped the economy. David Shapiro argues they have been replaced by spreadsheet managers, over-regulation and compliance paralysis, and explains what that loss means for growth, risk-taking and the country’s future.
8 Jan 6AM 54 min
All episodes